News | Proton Therapy | February 16, 2016

Mevion S250 Proton Therapy System Comes to Nation's Capital

Mevion proton accelerator arrives at Medstar Georgetown; one of multiple Mevion sites to achieve installation milestones

Mevion S250, proton therapy, Medstar Georgetown installation, Washington D.C.

February 16, 2016 – A superconducting synchrocyclotron proton accelerator was delivered Valentine’s Day weekend to MedStar Georgetown University Hospital. The accelerator, which will become the core of the hospital’s Mevion S250 proton therapy system, was developed and manufactured in the United States and is one of only eight in existence.

When installation is complete, cancer patients in the Washington, D.C. area will gain access to proton therapy — an advanced form of radiation treatment that targets tumors precisely, while sparing much of the surrounding healthy tissue. Because of its accuracy, proton therapy is ideal for treating pediatric patients, as well as adults with cancers in or near sensitive locations, such as the heart, lungs, brain, eye or spinal cord.

Conventional proton therapy systems can cost over $200 million to construct and are typically the size of a football field. The Mevion S250 delivers proton therapy for up to 80 percent less cost and 90 percent less space. Mevion systems also require up to 75 percent fewer staff and use up to 90 percent less energy than other proton systems. Furthermore, Mevion says its proton systems have an industry leading ramp-up time, throughput capabilities and uptime.

Installation of the system at MedStar Georgetown will take approximately 10 months. The system will then undergo proton beam tuning to meet the precise clinical requirements for patient treatments. The first proton therapy patient is expected to be treated at MedStar Georgetown in early 2017.

The Washington, D.C. installation begins as Ackerman Cancer Center (ACC) in Jacksonville, Fla., breaks ground on the construction of a radiation vault for its second Mevion S250 Series system. ACC will be installing a Mevion S250i with Hyperscan pencil beam scanning technology.

The first system opened last April, and quickly achieved the fastest per-room ramp-up in the history of proton therapy. The installation is expected to be completed in 2017.

Meanwhile, the Mevion S250 under installation at the University of Florida (UF) Health Cancer Center – Orlando Health, in Orlando, Fla., has also achieved a major milestone. It has completed its rigorous acceptance testing and is now entering the clinical commissioning phase. Clinical commissioning is the final step before the first patient is treated.

During an intensive seven days of acceptance testing, the system in Orlando met or exceeded all specifications. Its operational control has been officially transitioned to the physics and radiation oncology proton teams at UF Health Cancer Center. It is expected to begin treating patients in a few months.

For more information: www.mevion.com

Related Content

Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...